Music |
Video |
Movies |
Chart |
Show |
ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer (ecancer) View | |
Targeted therapy in NSCLC at ASCO 2020 (VJOncology) View | |
A Case of EGFR-Mutant Non–Small Cell Lung Cancer (Targeted Oncology) View | |
ASCO Lung Cancer Roundtable - Trial Updates in NSCLC - ADAURA Trial and Post Surgery EGFR Mutation (GRACE - Global Resource for Advancing Cancer Education) View | |
ASCO: Adjuvant Osimertinib for Resected EGFR-Positive Non-Small Cell Lung Cancer (PracticeUpdate) View | |
Key NSCLC updates (VJOncology) View | |
ASCO 2021 Lung Recap: Amivantamab and Mobocertinib for EGFR Exon 20 (GRACE - Global Resource for Advancing Cancer Education) View | |
ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer (ecancer) View | |
ASCO20 - New Research in Non-Small Cell Lung Cancer (HPR) View | |
Reflections on the ADAURA study (VJOncology) View |